CITIGROUP INC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$231
-76.9%
1,342
+4.4%
0.00%
Q3 2022$1,000
-50.0%
1,286
-35.0%
0.00%
Q2 2022$2,000
-98.9%
1,978
-93.9%
0.00%
Q1 2022$177,000
-86.7%
32,180
-76.6%
0.00%
-100.0%
Q4 2021$1,330,000
-21.7%
137,351
+44.7%
0.00%0.0%
Q3 2021$1,698,000
-62.6%
94,951
-48.9%
0.00%
-66.7%
Q2 2021$4,535,000
+2699.4%
185,780
+2944.1%
0.00%
Q1 2021$162,000
+95.2%
6,103
-44.3%
0.00%
Q4 2020$83,000
+118.4%
10,953
+42.7%
0.00%
Q3 2020$38,000
-62.4%
7,675
-54.7%
0.00%
Q2 2020$101,000
+40.3%
16,951
+4.6%
0.00%
Q1 2020$72,000
-47.8%
16,212
+11.2%
0.00%
Q4 2019$138,000
+360.0%
14,575
+280.7%
0.00%
Q3 2019$30,000
-83.5%
3,828
-67.0%
0.00%
Q2 2019$182,000
-2.2%
11,615
+12.9%
0.00%
Q1 2019$186,000
+126.8%
10,289
+202.6%
0.00%
Q3 2018$82,0003,4000.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders